Global Pharm acquires Shandong distributor as consolidation trend ramps
This article was originally published in Scrip
The Chinese pharmaceutical distributor Global Pharm Holdings Group has acquired 100% of Qingdao Likang Pharmaceutical, a regional distributor in the country, for $1.6 million in cash in a bid to expand its network in Shandong province.
You may also be interested in...
China is known for a global supplier of active pharmaceutical ingredients, but with continuous investment in advanced facilities and talents, it is likely to be a global supplier of biological therapies. The US approval of a 'made in China' monoclonal antibody for use in clinical trials marks a milestone in China's journey.
Shanghai-based, Hong Kong and Shanghai listed Fosun Pharmaceutical has been busy adding foreign assets under its belt.
Officials at the highest level of China's government have said that the quality of medicines on China's essential drugs list must be raised to international standards, a move that challenges the existing essential drugs scheme in the country1.